Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Chimerix Inc (CMRX)

5.045 0.025 (0.5%)

02-20 10:21

Open:

5.01

Pre. Close:

5.02

High:

5.06

Low:

4.99

Volume:

16,169

Market Cap:

238M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

5.177 - 5.198

5.198 - 5.218

Low:

4.879 - 4.902

4.902 - 4.923

Close:

4.984 - 5.019

5.019 - 5.053

Technical analysis  (as of: 2018-02-20 10:09:57 AM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 6.04     One year: 7.05

Support:

Support1: 4.81    Support2: 4.58

Resistance:

Resistance1: 5.17    Resistance2: 6.04

Pivot:

4.86

Moving Averages:

MA(5): 4.97     MA(20): 4.84

MA(100): 4.81     MA(250): 5.09

MACD:

MACD(12,26): 0.06     Signal(12,26,9): 0.04

%K %D:

%K(14,3): 78.25     %D(3): 78.57

RSI:

RSI(14): 63.66

52-Week:

High: 6.64  Low: 4.17  Change(%): -7.4

Average Vol(K):

3-Month: 31796  10-Days 31251

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
CMRX has closed below upper band by 11.6%. Bollinger Bands are 11.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 09 Feb 2018 06:11:15 GMT
Chimerix - Years Behind The Competition

Thu, 18 May 2017 13:41:15 GMT
Chimerix: This Misunderstood Biotech, Trading Near Cash, Offers Substantial Upside

Fri, 05 Jan 2018 12:00:00 GMT
Chimerix Initiates AdAPT Study for Oral Brincidofovir and Advances IV ...

Mon, 19 Feb 2018 00:45:00 GMT
Analysts See $-0.49 EPS for Chimerix, Inc. (CMRX)

Tue, 12 Sep 2017 10:52:30 GMT
Chimerix Appoints Heather Knight-Trent, PharmD, as Vice President of ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

47.13

Shares Float (M)

46.47

% Held by Insiders

% Held by Institutions

76.40

Shares Short (K)

1075

Shares Short Prior Month (K)

1340

Stock Financials

EPS

-1.430

EPS Est. Current Year

-1.630

EPS Est. Next Year

-1.850

EPS Est. Next Quarter

-0.480

Forward EPS

-1.819

Book Value (p.s.)

PEG Ratio

Profit Margin

Operating Margin

-1485.70

Return on Assets (ttm)

-24.0

Return on Equity (ttm)

-24.8

Qtrly Rev. Growth

37.4

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.436

Qtrly Earnings Growth

Operating Cash Flow (M)

-47.70

Levered Free Cash Flow (M)

-24.43

atoplab.com

Valuation

P/E

-3.52

P/E Growth Ratio

P/BV

5.04

P/S

2375352064.00

P/CF

-4.98

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.